Product Code: ETC13341410 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Naltrexone Buprenorphine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Naltrexone Buprenorphine Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Naltrexone Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Naltrexone Buprenorphine Market - Industry Life Cycle |
3.4 Europe Naltrexone Buprenorphine Market - Porter's Five Forces |
3.5 Europe Naltrexone Buprenorphine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Naltrexone Buprenorphine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.7 Europe Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Europe Naltrexone Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Europe Naltrexone Buprenorphine Market Revenues & Volume Share, By Administration Method, 2021 & 2031F |
3.10 Europe Naltrexone Buprenorphine Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
4 Europe Naltrexone Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Naltrexone Buprenorphine Market Trends |
6 Europe Naltrexone Buprenorphine Market, 2021 - 2031 |
6.1 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Formulation Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Oral Tablet, 2021 - 2031 |
6.1.3 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Sublingual Film, 2021 - 2031 |
6.1.4 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Injectable Form, 2021 - 2031 |
6.1.5 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Implant, 2020 - 2028 |
6.1.6 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Combination Form, 2020 - 2028 |
6.2 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Opioid Receptor Modulation, 2021 - 2031 |
6.2.3 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Partial Agonist, 2021 - 2031 |
6.2.4 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Long-Acting Effect, 2021 - 2031 |
6.2.5 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Sustained Release, 2021 - 2031 |
6.2.6 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Dual Mechanism, 2020 - 2028 |
6.3 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Opioid Dependence, 2021 - 2031 |
6.3.3 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Withdrawal Management, 2021 - 2031 |
6.3.4 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Relapse Prevention, 2021 - 2031 |
6.3.5 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Maintenance Therapy, 2021 - 2031 |
6.3.6 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Detoxification, 2021 - 2031 |
6.4 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Administration Method, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.4.3 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Sublingual, 2021 - 2031 |
6.4.4 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Injection, 2020 - 2028 |
6.4.5 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Subcutaneous, 2020 - 2028 |
6.4.6 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Oral, 2020 - 2028 |
6.5 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Patient Group, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Adults, 2020 - 2028 |
6.5.3 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Teenagers, 2020 - 2028 |
6.5.4 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Elderly, 2020 - 2028 |
6.5.5 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Critical Patients, 2020 - 2028 |
6.5.6 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By All Ages, 2020 - 2028 |
7 Europe Naltrexone Buprenorphine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Formulation Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Naltrexone Buprenorphine Market, Revenues & Volume, By Formulation Type, 2021 - 2031 |
7.2.2 Germany Naltrexone Buprenorphine Market, Revenues & Volume, By Formulation Type, 2021 - 2031 |
7.2.3 France Naltrexone Buprenorphine Market, Revenues & Volume, By Formulation Type, 2021 - 2031 |
7.2.4 Poland Naltrexone Buprenorphine Market, Revenues & Volume, By Formulation Type, 2021 - 2031 |
7.2.5 Spain Naltrexone Buprenorphine Market, Revenues & Volume, By Formulation Type, 2021 - 2031 |
7.2.6 Rest of Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Formulation Type, 2021 - 2031 |
7.3 Europe Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
7.3.1 United Kingdom (UK) Naltrexone Buprenorphine Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.3.2 Germany Naltrexone Buprenorphine Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.3.3 France Naltrexone Buprenorphine Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.3.4 Poland Naltrexone Buprenorphine Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.3.5 Spain Naltrexone Buprenorphine Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.3.6 Rest of Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.4 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United Kingdom (UK) Naltrexone Buprenorphine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Germany Naltrexone Buprenorphine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 France Naltrexone Buprenorphine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.4 Poland Naltrexone Buprenorphine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.5 Spain Naltrexone Buprenorphine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.6 Rest of Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Administration Method, 2021 - 2031 |
7.5.1 United Kingdom (UK) Naltrexone Buprenorphine Market, Revenues & Volume, By Administration Method, 2021 - 2031 |
7.5.2 Germany Naltrexone Buprenorphine Market, Revenues & Volume, By Administration Method, 2021 - 2031 |
7.5.3 France Naltrexone Buprenorphine Market, Revenues & Volume, By Administration Method, 2021 - 2031 |
7.5.4 Poland Naltrexone Buprenorphine Market, Revenues & Volume, By Administration Method, 2021 - 2031 |
7.5.5 Spain Naltrexone Buprenorphine Market, Revenues & Volume, By Administration Method, 2021 - 2031 |
7.5.6 Rest of Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Administration Method, 2021 - 2031 |
7.6 Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Patient Group, 2021 - 2031 |
7.6.1 United Kingdom (UK) Naltrexone Buprenorphine Market, Revenues & Volume, By Patient Group, 2021 - 2031 |
7.6.2 Germany Naltrexone Buprenorphine Market, Revenues & Volume, By Patient Group, 2021 - 2031 |
7.6.3 France Naltrexone Buprenorphine Market, Revenues & Volume, By Patient Group, 2021 - 2031 |
7.6.4 Poland Naltrexone Buprenorphine Market, Revenues & Volume, By Patient Group, 2021 - 2031 |
7.6.5 Spain Naltrexone Buprenorphine Market, Revenues & Volume, By Patient Group, 2021 - 2031 |
7.6.6 Rest of Europe Naltrexone Buprenorphine Market, Revenues & Volume, By Patient Group, 2021 - 2031 |
8 Europe Naltrexone Buprenorphine Market Key Performance Indicators |
9 Europe Naltrexone Buprenorphine Market - Export/Import By Countries Assessment |
10 Europe Naltrexone Buprenorphine Market - Opportunity Assessment |
10.1 Europe Naltrexone Buprenorphine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Naltrexone Buprenorphine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
10.3 Europe Naltrexone Buprenorphine Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
10.4 Europe Naltrexone Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 Europe Naltrexone Buprenorphine Market Opportunity Assessment, By Administration Method, 2021 & 2031F |
10.6 Europe Naltrexone Buprenorphine Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
11 Europe Naltrexone Buprenorphine Market - Competitive Landscape |
11.1 Europe Naltrexone Buprenorphine Market Revenue Share, By Companies, 2022 |
11.2 Europe Naltrexone Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |